Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / DVA - Dilution Could Cause Pop To Fizzle At TCR2 Therapeutics

DVA - Dilution Could Cause Pop To Fizzle At TCR2 Therapeutics

DaVita Inc.

TCR2 Therapeutics (TCRR) announced positive results of a Phase 1 trial on Monday, and the stock price is up over 50% in pre-market trading:

Source: Google Finance

TCR2's results may be promising indeed, but for the reasons stated below, traders and shareholders should be concerned about dilution and additional sales described in earlier securities filings.

1. Background and Phase 1 Results

As described in the company's Amended Form S-1, TCR2 is developing T-cell therapies for cancer patients. (I am in no way qualified or experienced with any of the relevant medical

Read more ...
Stock Information
Company Name: DaVita Inc.
Stock Symbol: DVA
Market: NYSE
Website: davita.com
Menu
DVA DVA Quote DVA Short DVA News DVA Articles DVA Message Board
Get DVA Alerts

News, Short Squeeze, Breakout and More Instantly...